Table 1. Patient demographics of the included studies.
| Author | Journal | Year | Country | Number of cases | Mean age (range) | Male:female | Stone free rate (%) | Stone size, mm (range) |
|---|---|---|---|---|---|---|---|---|
| Suliman et al. (15) | Urolithiasis | 2018 | England | 36 | 10.6 (1.4–15.7) | NR | 89.0 | 8 [3–23] |
| Freton et al. (16) | J Endourol | 2017 | France | 46 | 9.1 (±0.9 SD) | NR | 76.1 | 21.6 (±2.0 SD) |
| Corcoran et al. (17) | J Urol | 2008 | USA | 30 | 9.7 (2.2–14.4) | NR | 94.0 | 8.8 (1.5–25)—burden |
| Unsal and Resorlu (18) | J Pediatr Surg | 2011 | Turkey | 16 | 4.2 (0.8–7) | 9:7 | 88.0 | 11.5 [8–17]—burden |
| Yuruk et al. (19) | J Pediatr Urol | 2017 | Turkey | 14 | 10.9 [7–15] | 8:6 | 100.0 | 13.6 [10–18] |
| Baş et al. (20) | J Endourol | 2016 | Turkey | 36 | 8.4 [1–16] | 15:21 | 86.1 | 12.8 [10–19] |
| Erkurt et al. (21) | Urolithiasis | 2014 | Turkey | 65 | 4.3 (0.5–7) | 31:34 | 92.3 | 14.7 [7–30] |
| Yeow et al. (22) | J Indian Assoc Pediatr Surg | 2009 | Australia | 26 | 8.2 (0.25–15) | 14:12 | 88.5 | 10.3 [3–21] |
| Tanaka et al. (23) | J Urol | 2008 | USA | 50 | 7.9 (1.2–13.6) | 31:19 | 58.0 | 8.8 (1.5–25) |
| Resorlu et al. (24) | J Urol | 2012 | Turkey | 95 | 9.3 [1–17] | 53:42 | 92.6 | 14.3 [10–30] |
| Featherstone et al. (25) | J Pediatr Urol | 2017 | England | 17 | 10.8 (3.9–15) | 9:8 | 88.2 | 13.3 [10–25] |